Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neutralizing antibody to gB2 human cytomegalovirus does not prevent reactivation in patients with human immunodeficiency virus infection.

The Journal of general virology - 1 Jul 2003

Rasmussen Lucy, Cowan Catherine M

Abstract excerpt

The incidence of human cytomegalovirus (CMV) genotype gB2 (UL55) is high in patients with human immunodeficiency virus (HIV) infection in the San Francisco Bay area of California. Virus neutralizing antibody (NAb) to human CMV strain Ad169, a gB2 laboratory strain, was measured prospectively in HIV-infected patients, with CD4 T-lymphocyte counts <200, who were at risk for CMV-associated disease. Patients were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS-Related Opportunistic Infections
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytomegalovirus

Share to Genotype

Share to HIV Infections

Share to Neutralization Tests

Share to Viral Envelope Proteins

Share to Virus Activation

Source

Identifiers

PMID: 12810879
DOI: 10.1099/vir.0.18896-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neutralizing antibody to gB2 human cytomegalovirus does not prevent reactivation in patients with human immunodeficiency virus infection.PMID 12810879Read ↗

Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR.Semantic proximity Read ↗

Evaluation of glycoprotein B genotypes and load of CMV infecting blood leukocytes on prognosis of AIDS patients.Semantic proximity Read ↗

Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis.Semantic proximity Read ↗

Molecular pathogenesis of human cytomegalovirus infection.Semantic proximity Read ↗

Glycoprotein B genotype of human cytomegalovirus: distribution in HIV-infected patients.Semantic proximity Read ↗

Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients.Semantic proximity Read ↗

Cytomegalovirus Genetic Diversity Following Primary Infection.Semantic proximity Read ↗

Distinct genotypic distribution of cytomegalovirus (CMV) envelope glycoprotein B (gB) in a Cuban cohort of patients with different CMV diseases.Semantic proximity Read ↗

Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis.Semantic proximity Read ↗

Human cytomegalovirus glycoprotein B genotyping from bronchoalveolar lavage specimens.Semantic proximity Read ↗

Cytomegalovirus genotypes present in cerebrospinal fluid of HIV-infected patients.Semantic proximity Read ↗

Cytomegalovirus (CMV) Glycoprotein B Genotypes and Response to Antiviral Therapy, in Solid‐Organ–Transplant Recipients with CMV DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.